Boehringer Ingelheim Backs R&D With Big Bucks
Reports Solid Set Of Financials For 2020
Executive Summary
Jardiance and Ofev are growing strongly but the German drugmaker is also confident its pipeline will bear fruit, boosted by a rising research budget that represents almost 23% of sales.